Acurx Pharmaceuticals, Inc. (ACXP): Shareholders' Equity
$5.27M
As of 2025-12-31
$8.15M
As of 2026-06-30
-10.4%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.27M | +756.5% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $615.1K | -86.8% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $4.67M | -36.2% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $7.32M | -41.1% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $12.41M | n/a | 2023-03-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Acurx Pharmaceuticals, Inc. (ACXP) | 2025-12-31 | $5.27M | +756.5% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $6.31M | +25.3% |
| Rocket One Inc. (RKTO) | 2025-12-31 | $6.15M | -10.6% |
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | -$3.80M | n/m |
| Processa Pharmaceuticals, Inc. (PCSA) | 2025-12-31 | $5.58M | +228.8% |
| Dermata Therapeutics, Inc. (DRMA) | 2025-12-31 | $6.22M | +298.7% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $3.21M | -13.3% |
| Telomir Pharmaceuticals, Inc. (TELO) | 2025-12-31 | $5.91M | +819.6% |
| GT Biopharma, Inc. (GTBP) | 2025-12-31 | $5.79M | n/a |
Compare ACXP, SILO, RKTO, ONCY side by side · Screen every company in Pharmaceutical Preparations ↗